Rare Diseases Clinical Research Network (RDCRN) - PTEN hamartoma tumor syndrome is a genetic condition in which non-cancerous growths, called hamartomas, develop in different areas of the body. The disease is hereditary,
Comprehensive PTEN Hamartoma Tumor Syndrome (PHTS) Multidisciplinary Clinic | Children's Hospital of Philadelphia
Cleveland Clinic's 4th Annual International PTEN Symposium
References in KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
JCI - PTEN-opathies: from biological insights to evidence-based precision medicine
Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer - Urology
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium | British Journal of Cancer
Clinical implications of PTEN loss in prostate cancer | Nature Reviews Urology
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? | Journal of Translational Medicine | Full Text
Cancer risk and PTEN gene mutations
How are new medicines developed? | PTEN Research
65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine in: Endocrine-Related Cancer Volume 25 Issue 8 (2018)
Phase II and phase III clinical trials with translational analyses... | Download Scientific Diagram
PTEN Mutations Trigger Resistance to Immunotherapy: Trends in Molecular Medicine
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
Turning On the PTEN Tumor Suppressor Protein - NCI
Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors - ScienceDirect
Frontiers | The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors | Molecular Biosciences
Finally in the game: Patient in drug trial for PTEN mutation seems to benefit - Boston Children's Answers Early patient in drug trial for PTEN mutation seems to benefit
PTEN Hamartoma Tumor Syndrome Foundation - PTEN Foundation
PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity | NEJM
PTEN Hamartoma Tumor Syndrome Foundation - PTEN Foundation
Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers | Nature Communications
PLOS Medicine: Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer | Cell Death & Disease
